749884-42-2 Usage
Description
3-(3-CHLOROPHENYLSULFONAMIDO)BENZOIC ACID is a chemical compound that consists of a benzoic acid molecule with a substituent containing a sulfonamide and a chlorophenyl group. It is widely used in the pharmaceutical industry as a building block for the synthesis of various drugs, particularly as a nonsteroidal anti-inflammatory drug (NSAID) and as a diuretic. Additionally, this compound has demonstrated promising anticancer properties, making it a subject of interest in cancer research. It is important to handle this chemical with care and adhere to safety guidelines, as it can be hazardous if not handled properly.
Uses
Used in Pharmaceutical Industry:
3-(3-CHLOROPHENYLSULFONAMIDO)BENZOIC ACID is used as a building block for the synthesis of various drugs for its versatile chemical structure and functional groups.
Used in Nonsteroidal Anti-Inflammatory Drug (NSAID) Synthesis:
3-(3-CHLOROPHENYLSULFONAMIDO)BENZOIC ACID is used as a key component in the development of NSAIDs for its ability to reduce inflammation and pain.
Used in Diuretic Drug Development:
3-(3-CHLOROPHENYLSULFONAMIDO)BENZOIC ACID is used as a constituent in the formulation of diuretic drugs to promote the removal of excess water and salts from the body.
Used in Cancer Research:
3-(3-CHLOROPHENYLSULFONAMIDO)BENZOIC ACID is used as a subject of interest in cancer research for its demonstrated anticancer properties, potentially leading to the development of new cancer treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 749884-42-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,9,8,8 and 4 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 749884-42:
(8*7)+(7*4)+(6*9)+(5*8)+(4*8)+(3*4)+(2*4)+(1*2)=232
232 % 10 = 2
So 749884-42-2 is a valid CAS Registry Number.
749884-42-2Relevant articles and documents
Novel sulfonamides as L-CPT1 inhibitors
-
Page/Page column 16, (2010/11/25)
The invention is concerned with novel sulfonamide derivatives of formula (I) wherein R2, R3, R4, A, X, Y1, Y2, Y3, Y4 and Z1 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit L-CPT1 and can be used as medicaments.